BG99839A - Хетероароматни съединения с антипсихотичен ефект - Google Patents

Хетероароматни съединения с антипсихотичен ефект Download PDF

Info

Publication number
BG99839A
BG99839A BG99839A BG9983995A BG99839A BG 99839 A BG99839 A BG 99839A BG 99839 A BG99839 A BG 99839A BG 9983995 A BG9983995 A BG 9983995A BG 99839 A BG99839 A BG 99839A
Authority
BG
Bulgaria
Prior art keywords
butyl
benzisothiazol
piperazinyl
formula
compound
Prior art date
Application number
BG99839A
Other languages
Bulgarian (bg)
English (en)
Inventor
Mark Norman
Frank Navas
Original Assignee
Mark Norman
Frank Navas
The Wellcome Foundation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mark Norman, Frank Navas, The Wellcome Foundation Limited filed Critical Mark Norman
Publication of BG99839A publication Critical patent/BG99839A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG99839A 1993-02-10 1995-08-02 Хетероароматни съединения с антипсихотичен ефект BG99839A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939302622A GB9302622D0 (en) 1993-02-10 1993-02-10 Heteroaromatic compounds
PCT/GB1994/000265 WO1994018196A1 (en) 1993-02-10 1994-02-10 Heteroaromatic compounds with antipsychotic activity

Publications (1)

Publication Number Publication Date
BG99839A true BG99839A (bg) 1996-02-28

Family

ID=10730183

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99839A BG99839A (bg) 1993-02-10 1995-08-02 Хетероароматни съединения с антипсихотичен ефект

Country Status (15)

Country Link
EP (1) EP0683778A1 (fi)
JP (1) JPH08506337A (fi)
CN (1) CN1117731A (fi)
AU (1) AU6005194A (fi)
BG (1) BG99839A (fi)
CA (1) CA2155758A1 (fi)
CZ (1) CZ204495A3 (fi)
FI (1) FI953777A (fi)
GB (1) GB9302622D0 (fi)
HU (1) HUT73654A (fi)
IL (1) IL108601A0 (fi)
MX (1) MX9401080A (fi)
SK (1) SK99195A3 (fi)
WO (1) WO1994018196A1 (fi)
ZA (1) ZA94891B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776963A (en) 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5364866A (en) 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
ES2170177T3 (es) * 1995-03-17 2002-08-01 Aventis Pharma Inc Benzotienilpiperazinas sustituidas, su uso como medicamentos y procedimientos para su preparacion.
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
WO2002039988A2 (en) * 2000-11-14 2002-05-23 Merck Patent Gmbh Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists
EP1361875A2 (en) * 2001-02-16 2003-11-19 Aventis Pharmaceuticals Inc. Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
HUP0402092A3 (en) 2001-07-26 2010-06-28 Merck Patent Gmbh Use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts for preparation of pharmaceutical compositions
GB0222909D0 (en) * 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
GB0222912D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
BRPI0511993A (pt) * 2004-07-20 2008-01-22 Siena Biotech Spa compostos moduladores de receptores de acetilcolina nicotìnicos alfa7, composições farmacêuticas e usos terapêuticos dos mesmos
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them
US8981095B2 (en) 2011-07-28 2015-03-17 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of lurasidone and salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625181B2 (ja) * 1985-03-27 1994-04-06 住友製薬株式会社 新規なイミド誘導体
AU593194B2 (en) * 1986-09-26 1990-02-01 Sumitomo Pharmaceuticals Company, Limited Imide derivatives ,and their production and use
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
MX9201991A (es) * 1991-05-02 1992-11-01 Jonh Wyeth & Brother Limited Derivados de piperazina y procedimiento para su preparacion.

Also Published As

Publication number Publication date
CA2155758A1 (en) 1994-08-18
JPH08506337A (ja) 1996-07-09
MX9401080A (es) 1994-08-31
SK99195A3 (en) 1995-12-06
IL108601A0 (en) 1994-05-30
CZ204495A3 (en) 1996-03-13
FI953777A0 (fi) 1995-08-09
AU6005194A (en) 1994-08-29
GB9302622D0 (en) 1993-03-24
HU9501881D0 (en) 1995-08-28
WO1994018196A1 (en) 1994-08-18
CN1117731A (zh) 1996-02-28
ZA94891B (en) 1995-08-10
EP0683778A1 (en) 1995-11-29
FI953777A (fi) 1995-08-09
HUT73654A (en) 1996-09-30

Similar Documents

Publication Publication Date Title
AU2004308955B2 (en) Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
JP7175888B2 (ja) 選択的ｈｄａｃ１、２阻害剤としてのピペラジン誘導体
US8604050B2 (en) Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
AU2001271022B2 (en) Propane-1,3-dione derivatives
KR101941048B1 (ko) 아미노 알킬 치환 n-티에닐벤즈아미드 유도체
SK96494A3 (en) Piperazine and piperidine derivatives, and their use as antipsychotic
KR101738866B1 (ko) 안드로겐 수용체 길항제, 항암제로서 사이클릭 n,n'-다이아릴티오우레아 및 n,n'-다이아릴우레아, 이의 제조방법 및 이의 용도
WO2007038669A9 (en) Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
KR20030045187A (ko) 도파민 ｄ₃수용체 조절제 (정신병 치료제)로서 유용한테트라히드로벤즈아제핀 유도체
BG99839A (bg) Хетероароматни съединения с антипсихотичен ефект
JP2004509894A (ja) 置換アゼピノ［４，５−ｂ］インドリン誘導体
WO2007091948A2 (en) Novel spiro [imidazolidine-4, 3´-indole] 2, 2´,5´(1h) triones for treatment of conditions associated with vanilloid receptor 1
JP2007517843A (ja) Ｃｈｋ１阻害剤であるチオフェン誘導体
KR101386679B1 (ko) 신규한 아릴피페라진-함유 이미다졸 4-카복사마이드 유도체 및 이를 포함하는 약학 조성물
CZ20024199A3 (cs) Substituované 1-aminoalkyllaktamy a jejich použití jako antagonisty muskarinového receptoru
WO2008057775A2 (en) Heterocyclic amide compounds useful as kinase inhibitors
US8168634B2 (en) Thiazole derivatives as kinase inhibitors
JP5011097B2 (ja) カンナビノイドｃｂ１受容体のアゴニストとしての、（インドール−３−イル）−複素環誘導体
JP2008115175A (ja) 複素環化合物
KR20080105092A (ko) 피롤 유도체 또는 그의 염
KR940000829B1 (ko) 항정신병성 융합-환의 피리디닐 피페라진 유도체의 제조방법
JPH10139780A (ja) 新規な複素環式アミノメチル化合物、これらの製造方法及びこれらを含む医薬組成物
KR100248643B1 (ko) 아릴 및 헤테로아릴 알콕시나프탈렌 유도체
NZ286090A (en) 1,2,5-thiadiazole derivatives of indolylalkyl-pyridinyl- and pyrimidinylpiperazine, preparation and pharmaceutical compositions thereof
JPH09509957A (ja) 免疫調節剤としてのキノリン誘導体